Log In
Print
BCIQ
Print
Print this Print this
 

docetaxel (ATI-1123)

  Manage Alerts
Collapse Summary General Information
Company Azaya Therapeutics Inc.
DescriptionProtein stabilized nanoparticle (PSN) formulation of docetaxel
Molecular Target Tubulin
Mechanism of ActionMicrotubule stabilization
Therapeutic ModalityNanotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationSolid tumors
Indication DetailsTreat advanced solid tumors
Regulatory Designation

Partner

Canbridge Life Sciences Ltd.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today